828 related articles for article (PubMed ID: 9492054)
61. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
[TBL] [Abstract][Full Text] [Related]
62. Suppression of human prostate cancer cell growth by beta-lapachone via down-regulation of pRB phosphorylation and induction of Cdk inhibitor p21(WAF1/CIP1).
Choi YH; Kang HS; Yoo MA
J Biochem Mol Biol; 2003 Mar; 36(2):223-9. PubMed ID: 12689523
[TBL] [Abstract][Full Text] [Related]
63. The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells.
Tyagi A; Agarwal C; Agarwal R
Cell Cycle; 2002; 1(2):137-42. PubMed ID: 12429923
[TBL] [Abstract][Full Text] [Related]
64. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
Pan MH; Chen WJ; Lin-Shiau SY; Ho CT; Lin JK
Carcinogenesis; 2002 Oct; 23(10):1677-84. PubMed ID: 12376477
[TBL] [Abstract][Full Text] [Related]
65. Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer.
Yang ES; Maiorino CA; Roos BA; Knight SR; Burnstein KL
Mol Cell Endocrinol; 2002 Jan; 186(1):69-79. PubMed ID: 11850123
[TBL] [Abstract][Full Text] [Related]
66. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.
DeGregori J; Leone G; Ohtani K; Miron A; Nevins JR
Genes Dev; 1995 Dec; 9(23):2873-87. PubMed ID: 7498785
[TBL] [Abstract][Full Text] [Related]
67. Butyrate alters the expression and activity of cell cycle components in anaplastic thyroid carcinoma cells.
Greenberg VL; Williams JM; Boghaert E; Mendenhall M; Ain KB; Zimmer SG
Thyroid; 2001 Jan; 11(1):21-9. PubMed ID: 11272092
[TBL] [Abstract][Full Text] [Related]
68. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
Choi YH; Lee WH; Park KY; Zhang L
Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
[TBL] [Abstract][Full Text] [Related]
69. Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells.
Hosokawa Y; Yang M; Kaneko S; Tanaka M; Nakashima K
Biochem Mol Biol Int; 1995 Oct; 37(2):393-9. PubMed ID: 8673024
[TBL] [Abstract][Full Text] [Related]
70. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells.
Zhang K; Kumar R
Biochem Biophys Res Commun; 1994 Apr; 200(1):522-8. PubMed ID: 8166726
[TBL] [Abstract][Full Text] [Related]
71. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Lees E; Faha B; Dulic V; Reed SI; Harlow E
Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067
[TBL] [Abstract][Full Text] [Related]
72. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
Lepley DM; Pelling JC
Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
[TBL] [Abstract][Full Text] [Related]
73. p21 Disrupts the interaction between cdk2 and the E2F-p130 complex.
Shiyanov P; Bagchi S; Adami G; Kokontis J; Hay N; Arroyo M; Morozov A; Raychaudhuri P
Mol Cell Biol; 1996 Mar; 16(3):737-44. PubMed ID: 8622674
[TBL] [Abstract][Full Text] [Related]
74. Saucernetin-7 isolated from Saururus chinensis inhibits proliferation of human promyelocytic HL-60 leukemia cells via G0/G1 phase arrest and induction of differentiation.
Seo BR; Lee KW; Ha J; Park HJ; Choi JW; Lee KT
Carcinogenesis; 2004 Aug; 25(8):1387-94. PubMed ID: 15033903
[TBL] [Abstract][Full Text] [Related]
75. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
Singh RP; Agarwal C; Agarwal R
Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
Tyagi A; Agarwal C; Agarwal R
Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
[TBL] [Abstract][Full Text] [Related]
77. Rb and E2F-1 regulate telomerase activity in human cancer cells.
Crowe DL; Nguyen DC
Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653
[TBL] [Abstract][Full Text] [Related]
78. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A.
Rashid SF; Moore JS; Walker E; Driver PM; Engel J; Edwards CE; Brown G; Uskokovic MR; Campbell MJ
Oncogene; 2001 Apr; 20(15):1860-72. PubMed ID: 11313934
[TBL] [Abstract][Full Text] [Related]
79. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
Yu B; Lane ME; Wadler S
Biochem Pharmacol; 2002 Oct; 64(7):1091-100. PubMed ID: 12234612
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
